Halozyme To Report Third Quarter 2023 Financial and Operating Results

SAN DIEGO, Oct. 30, 2023 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its third quarter 2023 financial and operating results on Monday, November 6, 2023, following the close of trading. Halozyme will host a conference call on…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks